TerminatedNot Applicable

The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA

Stopped: Sponsor and investigators aligned to terminate this study.

China129 participantsStarted 2020-09-18

Plain-language summary

This study aims to test the effectiveness of positive airway pressure therapy on reducing clinical failure after rhythm control treatment and restoring with regular heart beat in atrial fibrillation patients with obstructive sleep apnea.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Paroxysmal: at least having one episode every month for the last recent 6 months. Each episode with symptoms lasting for over 30 minutes and at least one episode is documented (≥30 seconds episode length, documented by ECG).
✓. Persistent: lasting over 7 days to 1 year persistent AF with ECG documented.
✓. Ablation and restored on sinus rhythm after the procedure.
✓. Underwent medical or electrical cardioversion during hospitalization and restored on sinus rhythm before enrollment.

What they're measuring

Number of participants with documented AFib recurrence

Timeframe: From baseline to the event occurs, up to 6 months.

Trial details

NCT IDNCT04519489

SponsorPhilips (China) Investment CO., LTD

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2021-12-24

View on ClinicalTrials.gov More Atrial Fibrillation trials